Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
PR Newswire•26/10/2026•07:00 ET
0
Key Highlights
- ➤HCTI launches neurotechnology AI device sales and solutions across Malaysia and Indonesia
- ➤Malaysia and Indonesia launch markets represent more than 310 million people
- ➤Three revenue streams include devices, professional training, and recurring AI software subscriptions
- ➤First Malaysia Medical Device Authority regulatory submission targeted for Q1 2027
- ➤First locally assembled devices targeted in Malaysia for Q3 2027
Expert Statements
Ehsan Masoumi, Director, Quantum Nexis
“Making neurotechnology accessible requires more than supplying equipment. Professionals need the knowledge to interpret the information, select appropriate interventions and understand the limits of each technology.”
Ehsan Masoumi, Director, Quantum Nexis
“Our vision is to develop regional capability across devices, software, education and clinical practice, so that advances in neuroscience can contribute meaningfully to people’s mental health and everyday functioning.”
Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia PR Newswire
Malaysia and Indonesia, home to more than 310 million people with a fast-growing need for mental health care, form the initial focus of an initiative combining neuroscience devices, professional education and AI-supported mental healthcare
Get started
Create a free account to read the full story.